#Switzerland #Zurich #Polaroid Therapeutics #POLTX-Fiber™ #APT

Polaroid Therapeutics Introduces POLTX-Fiber™: A Breakthrough in Wound Care

Zürich, February 25, 2026 – Polaroid Therapeutics (PTx) has announced a significant milestone with the CE marking approval of its innovative product, POLTX-Fiber™. This is a notable achievement as it marks the first application of the company’s Antimicrobial Polymer Technology (APT™) in a medical device class IIb, specifically designed to optimize wound care management.

The Importance of POLTX-Fiber™

POLTX-Fiber™ is a highly advanced antimicrobial gel-forming fiber dressing that significantly enhances wound care practices. Its unique formulation, which includes Sodium Carboxymethylcellulose (CMC) fibers and reinforcing cellulose fibers, offers superior adaptability and comfort. When exposed to wound exudate, the APT™ technology effectively prevents bacterial colonization within the dressing, helping reduce the risk of infection without contributing to antimicrobial resistance, a growing concern in today’s medical landscape.

As it absorbs exudate, POLTX-Fiber™ transforms into a gel that maintains a moist wound environment, promoting autolytic debridement while also protecting the wound edges and surrounding skin from maceration. This multifunctional capability makes POLTX-Fiber™ suitable for a variety of wound types, including:

• - Moderate to heavily exudating wounds
• - Acute and chronic wounds
• - Venous ulcers, pressure injuries (stage II to IV), and diabetic ulcers
• - Surgical wounds, encompassing postoperative sites and wounds expected to heal by secondary intention
• - Traumatic wounds such as abrasions and lacerations
• - Exudating oncological wounds
• - Superficial wounds and cavities

Commitment to Patient-Centric Solutions

The announcement of the CE marking for POLTX-Fiber™ signifies a key step forward for Polaroid Therapeutics in their mission to enhance patient care through human-centered solutions based on cutting-edge science and technology. “Receiving the CE mark for POLTX-Fiber™ is a pivotal moment for us. We are dedicated to providing patients with advanced care options that meet the highest standards while addressing the real challenges faced in modern wound management,” stated Ran Frenkel, co-founder and CEO of PTx.

He added, “This product introduces our APT™ platform to the market, which embodies a novel antimicrobial polymer technology that aligns with rigorous healthcare standards.” With the certification in place, Polaroid Therapeutics is set to expand its reach across selected European markets.

Future Development and Expansion

The innovative POLTX-Fiber™ is just the beginning of a broader portfolio based on the APT™ technology. Following its CE marking, the company is actively preparing for its market introduction, collaborating with clinicians and wound care centers to gather clinical and patient feedback. PTx aims to leverage this feedback to enhance further developments and expand its product lineup for various wound care applications.

In conclusion, POLTX-Fiber™ represents a serious advancement in wound management technology, promising not only to meet but exceed the current standards of care in a critical area of healthcare. As PTx continues to innovate in this field, the future of wound management looks promising, bringing with it better outcomes for patients and healthcare providers alike.

About Polaroid Therapeutics

Founded in 2022 and based in Switzerland, Polaroid Therapeutics (PTx) is a biotech start-up dedicated to developing innovative antimicrobial technologies. Building on the legacy of the Polaroid brand, known for its pioneering work in instant photography, PTx is committed to creating medical solutions grounded in advanced scientific developments that prioritize human wellbeing. The APT™ platform developed by PTx is designed to provide controlled antimicrobial performance through structural design instead of chemical release, reflecting the company’s commitment to responsible innovation and effective management of antimicrobial resistance (AMR).

For further information on POLTX-Fiber™ and its application in modern wound care, visit Polaroid Therapeutics’ website.